Quick Takeaways
- Steven Michael Oliveira filed SCHEDULE 13G for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX).
- Disclosed ownership: 6.8%.
- Date of event: 20 Nov 2024.
Steven Michael Oliveira - 20 Nov 2024 SCHEDULE 13G Report for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX)
- Filing Manager
- Steven Michael Oliveira
- Reporting Manager
- Nemean Asset Management, LLC
- Symbol
- FBRX
- Shares outstanding
- 6,394,615 shares
- Disclosed Ownership
- 432,276 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Jan 2025, 20:13:21 UTC
- Date of event
- 20 Nov 2024
- Next filing
- 09 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Steven Michael Oliveira disclosed 6.8% ownership in Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX) on 20 Nov 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Jan 2025, 20:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nemean Asset Management, LLC | 6.8% | 432,276 | 0 | 432,276 | /s/ Steven Oliveira | Steven Oliveira, Authorized Signatory | |
| Steven M. Oliveira | 6.8% | 432,276 | 0 | 432,276 | /s/ Steven Oliveira | Steven Oliveira |